Buddleja Species Distributed in Mexico against Inflammatory Diseases, Their Therapeutic Activities, Secondary Metabolites and Biotechnology | Chapter 08 | Recent Advances in Biological Research Vol. 5

B. americana, B. cordata, B. parviflora, B. perfoliata, B. scordioides and B. sessiliflora, belonging to Buddleja Genus, are species distributed in Mexico reported in folk medicine to treat ills related to inflammatory processes. For some of them, this ethnopharmacological uses have been validated by scientific studies. Their phytochemistry has been related for their medicinal properties, being mainly iridoids, flavonoids and phenylethanoids because all of them are secondary metabolites credited with anti-inflammatory biological activity. Particularly, in folk medicine, those plants showing high concentrations of verbascoside secondary metabolite have been traditionally used to treat inflammation. In B. cordata, a cell culture has been developed since plant cell and tissue culture is a biotechnological tool that allows producing bioactive secondary metabolites in high concentrations as an alternative and sustainable form different to extraction from whole wild plants; meantime this protects wild medicinal plants from excessive use and collects. This cell culture produced verbascoside in a higher concentration than whole wild plant and the methanolic extract obtained from the cells demonstrated to be a satisfying anti-inflammatory agent on in vivo pre-clinical studies of acute and chronic inflammation, due to it modulates the production of interleukins expressed during an inflammatory process, lymphocytes tissue concentrations, decrease oxidative stress and leukocyte infiltration. New scientific studies should be done in those Buddleja species distributed in Mexico that have not credited its anti-inflammatory ethnomedicinal effect as well as to start on developing works to establish plant cell and tissue cultures. Moreover, new works should be continued about biotechnological advances on B. cordata. The aim of this work is to review the therapeutic activities, secondary metabolites and biotechnology advances of Buddleja species distributed in Mexico used against inflammatory diseases.

Author(s) Details

María Elena Estrada-Zúñiga
Centro de Investigación en Recursos Bióticos, Facultad de Ciencias, Universidad Autónoma del Estado de México, Carretera Toluca-Ixtlahuaca Km 14.5, San Cayetano CP 50295, Toluca, Estado de México, México.

Gabriel Alfonso Gutiérrez-Rebolledo
Departamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa, San Rafael Atlixco No. 186, Col. Vicentina CP 09340, México D.F., México.

Aurelio Nieto-Trujillo
Departamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa, San Rafael Atlixco No. 186, Col. Vicentina CP 09340, México D.F., México.

Dr. Antonio Bernabé-Antonio
Departamento de Madera, Celulosa y Papel, Centro Universitario de Ciencias Exactas e Ingenierías, Universidad de Guadalajara, Km. 15.5. Carretera Guadalajara-Nogales, Col. Las Agujas, CP 45010, Zapopan, Jalisco, México.

Francisco Cruz Sosa
Departamento de Biotecnología, Universidad Autónoma Metropolitana-Iztapalapa, San Rafael Atlixco No. 186, Col. Vicentina CP 09340, México D.F., México.

Read full article: http://bp.bookpi.org/index.php/bpi/catalog/view/68/802/619-1
View Volume: https://doi.org/10.9734/bpi/rabr/v5

Advertisement

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s